Literature DB >> 24854232

First experiences with an individual nasal olive in patients with hereditary haemorrhagic telangiectasia (HHT).

Basel Al Kadah1, George Papaspyrou, Mathias Schneider, Bernhard Schick.   

Abstract

Hereditary haemorrhagic teleangiectasia (HHT) is most notably characterized by vulnerable vascular formations of the nasal superficial mucosa. Epistaxis is one of the most common symptoms of the afflicted patients, with an incidence of more than 90 %. A variable series of treatments have been described, ranging from nasal ointments to the complete surgical occlusion of the nose. The objective of this pilot study is the presentation of first experiences in treating patients suffering from HHT and chronically recurrent epistaxis with an individual nasal olive made from silicone. Eleven patients (six men, five women) aging from 44 to 80 years with known HHT were treated at the ENT department of Homburg/Saar between October 2008 and July 2012 because of nasal bleeding by Nd:YAG laser or argon plasma coagulation. After the surgical treatment, an imprint of the nasal aditus was taken to manufacture an individual custom-made silicone nasal olive. Patients were wearing the nasal olive for 3-8 h a day. Check-ups were made every 6 months. Epistaxis severity score (ESS) was used pre- and post-nasal olive application. The observation period was 12-48 months. The utilization of the silicone nasal olive led to a distinct reduction of epistaxis events. Apart from the nasal olive, our patients needed no further treatment of the nose during the observation period except for a nasal ointment. Insertion and removal of the nasal olive were handled by the patients themselves. The local manipulation in handling the nasal olive caused no epistaxis itself. A significant improvement of the ESS and satisfaction was reported in all patients. Use of an individually manufactured silicone nasal olive is a promising extension to the established treatments of epistaxis in HHT patients. Tolerance towards this treatment by the patients was high due to the low personal burden and encumbrance. The extended use of the presented method in HHT patients may be beneficial. However, a more prolonged observation period is necessary in the future to judge the long-term efficiency of individual nasal olives.

Entities:  

Mesh:

Year:  2014        PMID: 24854232     DOI: 10.1007/s00405-014-3086-3

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  31 in total

1.  Septal dermoplasty for control of nosebleeds caused by hereditary hemorrhagic telangiectasia or septal perforations.

Authors:  W H SAUNDERS
Journal:  Trans Am Acad Ophthalmol Otolaryngol       Date:  1960 Jul-Aug

2.  Management of epistaxis in hereditary hemorrhagic telangiectasia. Review of 80 cases.

Authors:  T V McCaffrey; E B Kern; C F Lake
Journal:  Arch Otolaryngol       Date:  1977-11

3.  Hereditary hemorrhagic telangiectasia: what the otolaryngologist should know.

Authors:  S V Byahatti; E E Rebeiz; S M Shapshay
Journal:  Am J Rhinol       Date:  1997 Jan-Feb

4.  Outcome of septal dermoplasty in patients with hereditary hemorrhagic telangiectasia.

Authors:  Maria Luisa Fiorella; Douglas Ross; Katharine J Henderson; Robert I White
Journal:  Laryngoscope       Date:  2005-02       Impact factor: 3.325

5.  Histological evaluation of the effect of a miniature carbon dioxide laser on oral mucosa.

Authors:  T B Kardos; T Holt; M M Ferguson
Journal:  Int J Oral Maxillofac Surg       Date:  1989-04       Impact factor: 2.789

6.  Manifestations of hereditary hemorrhagic telangiectasia in children and adolescents.

Authors:  Benedikt J Folz; Barbara Zoll; Heiko Alfke; André Toussaint; Rolf F Maier; Jochen A Werner
Journal:  Eur Arch Otorhinolaryngol       Date:  2005-06-24       Impact factor: 2.503

7.  [Argon plasma coagulation and topically applied estriol. Long-term results in the treatment of hereditary hemorrhagic telangiectasia of the nasal mucosa].

Authors:  H Sadick; F Riedel; J Oulmi; K Hörmann; W F Bergler
Journal:  HNO       Date:  2003-02       Impact factor: 1.284

8.  The value of screening for multiple arterio-venous malformations in hereditary hemorrhagic telangiectasia: a diagnostic study.

Authors:  Benedikt J Folz; Ana Cerra Wollstein; Heiko Alfke; Anja A Dünne; Burkard M Lippert; Konrad Görg; Hans-Joachim Wagner; Siegfried Bien; Jochen A Werner
Journal:  Eur Arch Otorhinolaryngol       Date:  2003-12-17       Impact factor: 2.503

9.  Using the KTP/532 laser to control epistaxis in patients with hereditary hemorrhagic telangiectasia.

Authors:  C L Vickery; F A Kuhn
Journal:  South Med J       Date:  1996-01       Impact factor: 0.954

10.  Argon laser treatment of head and neck vascular lesions.

Authors:  J L Parkin; J A Dixon
Journal:  Otolaryngol Head Neck Surg       Date:  1985-04       Impact factor: 3.497

View more
  2 in total

1.  Influence of temporary nasal occlusion (tNO) on epistaxis frequency in patients with hereditary hemorrhagic telangiectasia (HHT).

Authors:  Kornelia E C Wirsching; Frank Haubner; Thomas S Kühnel
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-01-09       Impact factor: 2.503

2.  Update on Clinical Strategies in Hereditary Hemorrhagic Telangiectasia from an ENT Point of View.

Authors:  Kornelia E C Wirsching; Thomas S Kühnel
Journal:  Clin Exp Otorhinolaryngol       Date:  2016-07-21       Impact factor: 3.372

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.